journal article·2025-03Open access

Mechanism and application prospect of magnesium-based materials in cancer treatment

Yutong Ma, Yi Wang, Siwei Song, Xinyue Yu, Can Xu, Long Wan, Fan Yao, Ke Yang, Frank Witte, Shude Yang

Journal of Magnesium and Alloys· Volume 13· Issue 3

Abstract

• The degradation of magnesium-based materials is influenced by various in vivo and in vitro factors, exerting antitumor effects through their degradation products. • Mg ions can comprehensively modulate the occurrence and metastasis of tumors through mechanisms including oxidative stress, inflammatory responses, gene expression, and so on. • H₂ can suppress the tumorigenesis via distinct mechanisms of antioxidant and anti-inflammatory action. • Mg(OH) 2 can regulate the lactic acids and alter the local pH, impacting the tumor development. • The clinical use of magnesium-based materials in combination with various therapeutic approaches enhances the potential for cancer treatment. Magnesium-based materials, including magnesium alloys, have emerged as a promising class of biodegradable materials with potential applications in cancer therapy due to their unique properties, including biocompatibility, biodegradability, and the ability to modulate the tumor microenvironment. The main degradation products of magnesium alloys are magnesium ions (Mg 2+ ), hydrogen (H 2 ), and magnesium hydroxide (Mg(OH) 2 ). Magnesium ions can regulate tumor growth and metastasis by mediating the inflammatory response and oxidative stress, maintaining genomic stability, and affecting the tumor microenvironment. Similarly, hydrogen can inhibit tumorigenesis through antioxidant and anti-inflammatory properties. Moreover, Mg(OH) 2 can alter the pH of the microenvironment, impacting tumorigenesis. Biodegradable magnesium alloys serve various functions in clinical applications, including, but not limited to, bone fixation, coronary stents, and drug carriers. Nonetheless, the anti-tumor mechanism associated with magnesium-based materials has not been thoroughly investigated. This review provides a comprehensive overview of the current state of magnesium-based therapies for cancer. It highlights the mechanisms of action, identifies the challenges that must be addressed, and discusses prospects for oncological applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Magnesium in Health and Disease · Magnesium Alloys: Properties and Applications · Hydrogen's biological and therapeutic effects

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Siegel · CA Cancer J Clin · 2024 · 74 · 1210.3322/caac.21820 ↗
2. Bray · CA Cancer J Clin · 2024 · 74 · 22910.3322/caac.21834 ↗
3. Passaro · J Clin Oncol · 2022 · 40 · 59810.1200/JCO.21.01845 ↗
4. Stenör · Ugeskr Laeger · 2021 · 183
5. Inohara · Int J Radiat Oncol Biol Phys · 2015 · 91 · 93410.1016/j.ijrobp.2014.12.032 ↗
6. Rapoport · Expert Rev Clin Pharmacol · 2021 · 14 · 29510.1080/17512433.2021.1884067 ↗
7. Narayana · J Nanobiotechnology · 2024 · 22 · 42710.1186/s12951-024-02701-3 ↗
8. Das · Molecules · 2022 · 2710.3390/molecules27217326 ↗
9. Chen · J Biomater Appl · 2019 · 33 · 134810.1177/0885328219834656 ↗
10. Huse · Chic Med J Exam · 1878 · 37 · 171
11. Witte · Acta Biomaterialia · 2010 · 6 · 168010.1016/j.actbio.2010.02.028 ↗
12. Zheng · Mater Sci Eng: R: Rep · 2014 · 77 · 110.1016/j.mser.2014.01.001 ↗
13. Cao · Mater Lett · 2024 · 36010.1016/j.matlet.2024.136049 ↗
14. Dai · J Biomed Mater Res B Appl Biomater · 2019 · 107 · 253710.1002/jbm.b.34344 ↗
15. Qiao · ACS Biomater Sci Engineer · 2020 · 6 · 175510.1021/acsbiomaterials.9b01703 ↗
16. Mendes · Biolog Trace Element Res · 2018 · 184 · 33410.1007/s12011-017-1207-8 ↗
17. Chakraborty Banerjee · Materials (Basel) · 2019 · 1210.3390/ma12010136 ↗
18. Xu · J Magnes Alloys · 2023 · 11 · 76310.1016/j.jma.2023.02.007 ↗
19. Yang · Nat Commun · 2022 · 13 · 233610.1038/s41467-022-29938-6 ↗
20. Mills · Lancet · 1974 · 2 · 78110.1016/S0140-6736(74)90977-5 ↗
21. Zeng · Sci Rep · 2015 · 5 · 1302610.1038/srep13026 ↗
22. Pogorielov · Interv Med Appl Sci · 2017 · 9 · 27
23. Costello · Adv Nutr · 2021 · 12 · 29110.1093/advances/nmaa160 ↗
24. Volpe · Adv Nutr · 2013 · 4 · 378s10.3945/an.112.003483 ↗
25. Shahin · Acta Biomaterialia · 2019 · 96 · 110.1016/j.actbio.2019.06.007 ↗
26. Zan · Bioact Mater · 2022 · 9 · 385
27. Globig · Bioact Mater · 2023 · 19 · 594
28. Wang · Materials (Basel) · 2022 · 15
29. Amukarimi · Bioengineering (Basel) · 2022 · 9
30. Xin · Acta Biomater · 2011 · 7 · 145210.1016/j.actbio.2010.12.004 ↗
31. Xin · Acta Biomater · 2008 · 4 · 200810.1016/j.actbio.2008.05.014 ↗
32. Cui · Materials (Basel) · 2018 · 11
33. Liu · Water Res · 2023 · 245
34. Iskandar · J Mater Sci Mater Med · 2015 · 26 · 18910.1007/s10856-015-5512-5 ↗
35. Lee · Polymers (Basel) · 2020 · 12
36. Hong · Acta Biomaterialia · 2019 · 98 · 14210.1016/j.actbio.2019.05.048 ↗
37. Yan · Bioact Mater · 2020 · 5 · 318
38. Wang · Materials (Basel) · 2017 · 10
39. Zhang · Front Bioeng Biotechnol · 2022 · 10
40. Gao · Acta Biomater · 2019 · 83 · 47710.1016/j.actbio.2018.11.019 ↗
41. Peron · J Mech Behav Biomed Mater · 2022 · 12510.1016/j.jmbbm.2021.104945 ↗
42. Virtanen · Mater Sci Engineer: B · 2011 · 176 · 160010.1016/j.mseb.2011.05.028 ↗
43. Sanchez · Acta Biomaterialia · 2015 · 13 · 1610.1016/j.actbio.2014.11.048 ↗
44. Zhou · Corrosion Sci · 2010 · 52 · 103510.1016/j.corsci.2009.11.030 ↗
45. Zhen · Transact Nonferrous Met Soc China · 2013 · 23 · 228310.1016/S1003-6326(13)62730-2 ↗
46. Wen · J Alloys Compounds · 2009 · 488 · 39210.1016/j.jallcom.2009.08.147 ↗
47. Witte · Biomaterials · 2007 · 28 · 216310.1016/j.biomaterials.2006.12.027 ↗
48. Wong · Biomaterials · 2010 · 31 · 208410.1016/j.biomaterials.2009.11.111 ↗
49. Kraus · Acta Biomaterialia · 2012 · 8 · 123010.1016/j.actbio.2011.11.008 ↗
50. Hassan · Int J Mol Sci · 2022 · 2310.3390/ijms23116099 ↗
51. Tong · ACS Appl Bio Mater · 2022 · 5 · 234010.1021/acsabm.2c00167 ↗
52. Gao · Bioinorg Chem Appl · 2022 · 202210.1155/2022/8289447 ↗
53. Peng · ACS Biomater Sci Eng · 2018 · 4 · 411210.1021/acsbiomaterials.8b01184 ↗
54. A. Milenin, et al., Materials (Basel), 14 (21), 2021, 6673.10.3390/ma14216673 ↗
55. Anisimova · J Biomed Mater Res B Appl Biomater · 2020 · 108 · 16710.1002/jbm.b.34375 ↗
56. Martynenko · Materials Science and Engineering: A · 2018 · 712 · 62510.1016/j.msea.2017.12.026 ↗
57. Hakimi · Mater Sci Eng C Mater Biol Appl · 2016 · 61 · 51610.1016/j.msec.2015.12.043 ↗
58. Aghion · Advanced Engineering Materials · 2014 · 16 · 36410.1002/adem.201300201 ↗
59. Anisimova · Mater Sci Eng C Mater Biol Appl · 2021 · 13010.1016/j.msec.2021.112464 ↗
60. Sudha · Bioengineering (Basel) · 2024 · 11
61. Li · J Mater Sci Mater Med · 2021 · 32 · 4310.1007/s10856-021-06516-8 ↗
62. Zhang · Bioact Mater · 2022 · 17 · 394
63. Cheng · ACS Biomater Sci Eng · 2023 · 9 · 494010.1021/acsbiomaterials.3c00357 ↗
64. Shao · Regen Biomater · 2021 · 8 · rbab05310.1093/rb/rbab053 ↗
65. Kannan · ACS Appl Bio Mater · 2020 · 3 · 440810.1021/acsabm.0c00400 ↗
66. Chen · J Magnes Alloys · 2023 · 11 · 420610.1016/j.jma.2023.07.018 ↗
67. Li · Bioact Mater · 2024 · 40 · 474
68. Vidal · Int J Oncol · 2011 · 38 · 1365
69. Wu · Sci Rep · 2016 · 6 · 2173610.1038/srep21736 ↗
70. W. Xie, et al., ACS Biomater Sci Eng, 10(8), 2024, 5226-5236.10.1021/acsbiomaterials.4c00555 ↗
71. Shi · ACS Biomater Sci Eng · 2023 · 9 · 544110.1021/acsbiomaterials.3c00509 ↗
72. Sharma · IET Nanobiotechnol · 2020 · 14 · 85810.1049/iet-nbt.2019.0348 ↗
73. Wang · Adv Mater · 2020 · 32
74. Li · ACS Appl Mater Interfaces · 2020 · 12 · 3006610.1021/acsami.0c06102 ↗
75. Moussa · Intractable Rare Dis Res · 2022 · 11 · 8110.5582/irdr.2022.01057 ↗
76. Zhang · Asian Pac J Cancer Prev · 2015 · 16 · 7110.7314/APJCP.2015.16.1.71 ↗
77. Kacperczyk-Bartnik · Ginekol Pol · 2019 · 90 · 49610.5603/GP.2019.0086 ↗
78. Dana · Int J Vitam Nutr Res · 2021 · 91 · 53910.1024/0300-9831/a000598 ↗
79. Fernandes · Life Sci · 2024 · 33810.1016/j.lfs.2023.122390 ↗
80. Stankovic · Exp Mol Pathol · 2016 · 101 · 3110.1016/j.yexmp.2016.05.012 ↗
81. Mayer · Nature · 1984 · 309 · 26110.1038/309261a0 ↗
82. Nielsen · J Inflamm Res · 2018 · 11 · 2510.2147/JIR.S136742 ↗
83. Bae · Biochem Biophys Res Commun · 2003 · 305 · 109410.1016/S0006-291X(03)00869-6 ↗
84. Hayden · Semin Immunol · 2014 · 26 · 25310.1016/j.smim.2014.05.004 ↗
85. Zhao · Signal Transduct Target Ther · 2021 · 6 · 26310.1038/s41392-021-00658-5 ↗
86. Draghi · J Diet Suppl · 2022 · 19 · 48310.1080/19390211.2021.1897056 ↗
87. Derynck · Nat Rev Clin Oncol · 2021 · 18 · 910.1038/s41571-020-0403-1 ↗
88. Ashique · J Health Popul Nutr · 2023 · 42 · 7410.1186/s41043-023-00423-0 ↗
89. Al-Fahdawi · Biomed Pharmacother · 2021 · 13810.1016/j.biopha.2021.111483 ↗
90. Hoşgörler · Biol Trace Elem Res · 2020 · 196 · 54510.1007/s12011-019-01944-8 ↗
91. Liu · JCI Insight · 2019 · 4
92. Gupta · Cell Rep · 2023 · 4210.1016/j.celrep.2023.113232 ↗
93. Plutzky · Circulat Res · 2011 · 108 · 100210.1161/CIRCRESAHA.110.226860 ↗
94. Li · Biol Trace Elem Res · 2023 · 201 · 289510.1007/s12011-022-03393-2 ↗
95. Leidi · Eur J Cell Biol · 2010 · 89 · 65410.1016/j.ejcb.2010.05.001 ↗
96. Cazzaniga · Int J Molecul Sci · 2018 · 19
97. Locatelli · Int J Mol Sci · 2021 · 2210.3390/ijms22031050 ↗
98. Fedele · Nutrients · 2024 · 1610.3390/nu16101406 ↗
99. Pachikian · J Nutr · 2010 · 140 · 50910.3945/jn.109.117374 ↗
100. Li · Cell Host Microbe · 2024 · 32 · 4810.1016/j.chom.2023.11.006 ↗